Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	13	12	18	3	3	3
Market Cap Growth	128.79%	-33.91%	573.89%	7.89%	-27.33%	-47.37%
Enterprise Value	15	14	21	5	4	4
Last Close Price	0.41	0.38	0.57	0.10	0.11	0.15
PE Ratio	-	-	11.78	-	-	13.89
PS Ratio	1.64	1.50	1.44	0.32	0.26	0.31
PB Ratio	1.29	1.18	1.58	0.27	0.23	0.27
P/TBV Ratio	1.32	1.21	1.62	0.29	0.25	0.29
P/FCF Ratio	30.30	27.75	-	-	2.04	-
P/OCF Ratio	27.04	24.76	-	-	1.97	24.90
EV/Sales Ratio	1.90	1.78	1.67	0.56	0.42	0.40
EV/EBITDA Ratio	-	-	34.91	-	-	8.93
EV/EBIT Ratio	-	-	55.85	-	-	19.59
EV/FCF Ratio	35.12	32.93	-	-	3.34	-
Debt / Equity Ratio	0.28	0.28	0.26	0.31	0.29	0.28
Debt / EBITDA Ratio	-	-	4.12	-	-	5.89
Debt / FCF Ratio	6.65	6.65	-	-	2.61	-
Net Debt / Equity Ratio	0.21	0.21	0.19	0.13	-0.06	0.05
Net Debt / EBITDA Ratio	-3.78	-3.78	3.60	-4.36	2.68	1.36
Net Debt / FCF Ratio	4.82	4.82	-3.29	-0.58	-0.50	-3.40
Asset Turnover	0.41	0.41	0.67	0.50	0.53	0.57
Inventory Turnover	1.83	1.83	2.95	1.88	2.65	3.20
Quick Ratio	0.55	0.55	0.79	0.58	0.82	0.92
Current Ratio	0.96	0.96	1.06	1.09	1.12	1.21
Return on Equity (ROE)	-7.34%	-7.34%	13.14%	-8.82%	-5.42%	3.33%
Return on Assets (ROA)	-3.14%	-3.14%	1.25%	-1.90%	-1.66%	0.72%
Return on Invested Capital (ROIC)	-7.93%	-7.57%	2.71%	-4.86%	-4.32%	1.62%
Return on Capital Employed (ROCE)	-9.50%	-9.50%	3.20%	-5.10%	-4.30%	1.70%
Earnings Yield	-6.01%	-6.57%	8.49%	-34.12%	-27.61%	7.20%
FCF Yield	3.30%	3.60%	-3.63%	-83.72%	49.05%	-5.71%
Buyback Yield / Dilution	-6.13%	-6.13%	-13.08%	-14.85%	-	-